We hear from so many afib patients every day about the trials, tribulations, and fears regarding being on amiodarone, or their refusal to take it. Since the FDA approved Multaq® (dronedarone) recently, the most frequent question I’ve fielded has been “When will Multaq® be available?” That happened this week, and the excitement they have shared with us has been palpable.
So, on behalf of the atrial fibrillation patient community, StopAfib.org felt it was appropriate to thank and applaud the U.S. Food and Drug Administration (FDA) for providing a safer option for those with atrial fibrillation and atrial flutter. Dronedarone is the first new anti-arrhythmic drug approved in years for afib. There are now more options for fighting that afib beast. Read more: